Search alternatives:
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
stat decrease » small decrease (Expand Search), mean decrease (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
marked decrease » marked increase (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
stat decrease » small decrease (Expand Search), mean decrease (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs.
Published 2025“…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. There was no increase in pJAK2 with CHZ868 treatment; (B) pSTAT1 proportion peaked after 60 minutes and was greater after Type I JAKinib withdrawal than Type II JAKinib withdrawal; <b>(C)</b> The pSTAT2 proportion peaked 60 minutes after Type I JAKinib withdrawal but this phenomenon was not seen with Type II JAKinib withdrawal.…”
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Improving QoL through the use of STAT-ON™.
Published 2025“…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. …”